Cargando…
Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B Guidelines
BACKGROUND AND PURPOSE: The regulatory guidelines (ICHS7B) recommending inhibition of the delayed rectifier K(+) current (I(Kr)), carried by human ether-a-go-go-related gene (hERG) channels in cardiac cells (the hERG test), as a ‘first line' test for identifying compounds inducing QT prolongati...
Autores principales: | Lu, H R, Vlaminckx, E, Hermans, A N, Rohrbacher, J, Van Ammel, K, Towart, R, Pugsley, M, Gallacher, D J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2440085/ https://www.ncbi.nlm.nih.gov/pubmed/18493243 http://dx.doi.org/10.1038/bjp.2008.191 |
Ejemplares similares
-
Effect of QT interval-prolonging drugs taken in pregnancy on the neonatal QT interval
por: Michel, Holger, et al.
Publicado: (2023) -
Mexiletine shortens the QT interval in a pedigree of KCNH2 related long QT syndrome
por: Fujisawa, Taishi, et al.
Publicado: (2020) -
The effect of changes in core body temperature on the QT interval in beagle dogs: a previously ignored phenomenon, with a method for correction
por: van der Linde, H J, et al.
Publicado: (2008) -
QT Interval Shortening With Isavuconazole: In Vitro and In Vivo Effects on Cardiac Repolarization
por: Keirns, J, et al.
Publicado: (2017) -
Manual vs. automatic assessment of the QT-interval and corrected QT
por: Neumann, Benjamin, et al.
Publicado: (2023)